An exciting area in drug development, immunotherapy is being increasingly utilized by patients with different cancer types. These treatments...
While Cancer Research Catalyst covers the spectrum of cancer research news, we weren’t surprised to discover that the hottest...
Much has been written, including on this blog, about the rapidly expanding use of immunotherapy to treat an increasing...
In recent years, the U.S. Food and Drug Administration has approved immune checkpoint inhibitors, a class of immunotherapy, to...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which immunotherapeutics...
This week, some of the world’s leading cancer researchers are gathering in Mainz/Frankfurt, Germany for the Third International Cancer...
Yesterday marked a much anticipated milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced the...
A pair of studies published recently in journals of the American Association for Cancer Research bring to our attention...
Three years ago, the American Association for Cancer Research (AACR) launched this blog with a welcome post from Chief...
At the end of last week, the U.S. Food and Drug Administration (FDA) approved expanding the use of pembrolizumab...